Thursday, November 4, 2010

Contact for CCSVI tracking project

If you are having trouble getting signed up for the tracking project, please send an e-mail to margreet who is at ccsvi-tracking.com and is managing the site (I'm not putting the @ in there so she doesn't get spam).
Posted by at

4 comments:

  1. CCSVI ClinicJanuary 6, 2011 at 2:30 AM

    This comment has been removed by a blog administrator.

    ReplyDelete
  2. CCSVI ClinicJanuary 11, 2011 at 9:57 PM

    This comment has been removed by a blog administrator.

    ReplyDelete
  3. Greg MillsMarch 9, 2011 at 11:41 AM

    This comment has been removed by a blog administrator.

    ReplyDelete
  4. AnonymousJanuary 30, 2013 at 6:21 AM

    Strategic Importance of Jugular Vein Dilatation Otherwise Known as ‘Liberation Therapy’
    The Combination Therapy includes neck vein dilatation based on the findings of Zamboni, et al. The vein dilatation or venoplasty therapy provides the appropriate drainage of the CNS that prevents a retrograde pressure exertion on the myelin sheath covering the CNS. Whatever triggers the autoimmune system to turn on in people predisposed to MS, this back-pressure needs to be resolved. In case after case, the typical symptoms of MS retreat in individuals where the veins are expanded and the flow pressures are equalized. Since keeping the jugular and azygous veins fully open is the key to reducing MS symptoms, it is of paramount importance to know what other post-procedure factors create enduring effect in the venous flow. For example, there is now good clinical and observational evidence to support the fact that stem cells (transplanted intravenously at the time of the venoplasty) reduce swelling, thrombin buildup, clotting and subsequent permanent intraluminal damage leading to scar tissue. As to what has already been established through clinical trials and subsequent therapeutic practice, it has been found that even in patients with severely malformed or abnormal jugular vein structure, the intravenous introduction of autologous stromal cells (MSCs) post-operatively has served to repair injury attributable to venoplastic damage and desquamation of the endothelial and subendothelial cells of the interior venous lumen (tunica intima). Peak velocity, time average velocity vein area, and flow quantification have been assessed by means of echo color Doppler at periodic intervals post-venoplasty. Significant hemodynamic improvement has been recorded at the level of the veins in the neck post-venoplasty. Moreover, this additional stem cell transplantation therapy has led to increased luminal diameter and improved patency rates demonstrating that the introduction of stem cells post-operatively significantly modifies the hemodynamics of the jugular veins more effectively than venoplasty alone.For more information please visit http://www.ccsviclinic.ca/?p=1194 or you may call the toll free number at 888-468-1554 or info@ccsviclinic.com

    ReplyDelete

Subscribe to: Post Comments (Atom)